Yesterday (September 26th), Karen Keely of the FACS Forum Ireland addressed the EMA's public hearing on valproate in London. The hearing was investigating whether 2014 European-wide measures to restrict the use of valproate in girls and women of childbearing potential have been effective and whether additional measures to reduce risks associated with the drug are needed.
Irish mum Karen Keely to speak at European Medicines Agency public hearing on valproate in London today. The hearing is broadcast live on the EMA website from 1pm.
The BBC are today reporting that almost 70% of women surveyed about the epilepsy drug sodium valproate (Epilim) have not received new safety warnings about the dangers of taking it during pregnancy.
At the 2017 National Conference in Clayton Hotel last Saturday, Epilepsy Ireland recognised two special volunteers.
Taoiseach launches four new world-class Science Foundation Ireland Research Centres
Epilepsy cases are increasing according to new US study
RNS technology helps American woman's epilepsy
Epilepsy Ireland supports new study on whether dogs can predict seizures
The Epilepsy Lighthouse Project Providing Individualised Services and Care in Epilepsy (PISCES)
Upcoming Genetic Research: Could it Potentially be the Answer?